Company Profile
X-Biotech (hereinafter referred to as the Company) focuses on the field of biomedicine. Currently, the Company's products focus on the research and development of genetically engineered antibodies, mainly nanobodies, and the development and production of high-level recombinant proteins expressed in mammalian cells, prokaryotic and yeast, providing high-level biological reagents, high-quality antigens and antibody raw materials and services for life science research and in vitro diagnostics (IVD), replacing imports and exports of biological reagents.At present, the Company includes Anhui X-Biotech Co.,Ltd., Chengdu X-Biotech Co.,Ltd., and Sichuan X-Biotech Co.,Ltd..
Anhui X-Biotech Co.,Ltd. was established in July 2016, focusing on the research and development, production and sales services of prokaryotic and yeast recombinant proteins, producing high-end biological reagents that have doubled annual sales revenue over the past five years since their launch.
Chengdu X-Biotech Co.,Ltd. was established in July 2020 and its laboratory is currently located in Tianfu Life Science Park in Chengdu High-tech Zone. Mainly focus on new product development and production and provide R&D technical services, and product sales; the company's new product development is strongly supported by the company's product sales, and currently invests more than millions in R&D expenses each year, and is increasing rapidly.
In 2022, the Company purchased the building 11 of Lian Dong U Valley, No. 269 Phoenix Road, Chengdu Tian Fu International Bio City as the R&D for its development, and as a production experimental base, it was namely registered Sichuan X-Biotech Co.,Ltd. in December 2022, and will be settled at the end of 2023.
